3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Pulmonary Embolism
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Gene Expression Profiling
33
Flow Cytometry
30
Microarray Analysis
22
Polymerase Chain Reaction
21
Reverse Transcriptase Polymerase Chain Reaction
13
Amplified Fragment Length Polymorphism Analysis
11
Cytogenetic Analysis
10
Surveys and Questionnaires
9
DNA Methylation
9
Blotting, Western
9
Psychiatric Rehabilitation
8
Immunologic Techniques
8
Base Sequence
8
In Situ Hybridization, Fluorescence
6
Blood Specimen Collection
6
Interviews as Topic
5
Therapeutics
3
Immunoenzyme Techniques
3
Imatinib Mesylate
3
Gene Rearrangement
3
Watchful Waiting
2
Pharmacogenomic Testing
2
Mental Status and Dementia Tests
2
Mass Spectrometry
2
Genetic Testing
2
Data Collection
2
Dasatinib
2
Counseling
2
Cell Culture Techniques
2
Blotting, Southern
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Leukemia
×
Tinzaparin
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled